Reference entry · Synthetic tripeptide bioregulator
Pinealon
Also known as: Glu-Asp-Arg · EDR tripeptide
- Class
- Synthetic tripeptide bioregulator
- Size
- 3 amino acids
- Primary targets (literature)
- Neuronal gene expression literature (Khavinson lineage)
- Regulatory context
- Not FDA-approved. Neuroprotective preclinical reports are not cognitive or therapeutic claims for catalog material.
Overview
Pinealon is a Glu-Asp-Arg tripeptide bioregulator studied in neuroprotective and brain-aging research from the Khavinson literature. It is analytically tractable but often sold without adequate batch characterization.
Mechanism in research literature
Published models explore neuronal gene-expression changes and oxidative-stress resistance in cell culture and rodent brain-aging paradigms.
Common research focus areas
- Neuronal cell stress and survival assays
- Brain aging and cognitive endpoint literature
- Tripeptide MS/HPLC identity confirmation
- Distinction from epithalon and other short bioregulators
Full literature roundup
Read the cited research summary
A Glu-Asp-Arg tripeptide bioregulator studied in neuroprotective and brain-aging research. What the Khavinson literature describes — and what remains unestablished clinically.
Pinealon research roundup · 7 minEvaluate catalog material
- COA literacy — read batch documentation before comparing vendors.
- Peptide identity testing — why sequence confirmation matters beyond purity %.
- How we vet sources — our score methodology for recommended vendors.